AccessPak for HIV PEP Expanded with Viracept and Brethine Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Brethine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: terbutaline
Brand name: Brethine
Synonyms: Brethine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Bretylium
- AccessPak for HIV PEP Expanded with Viracept-Bretylium Injection
- AccessPak for HIV PEP Expanded with Viracept-Brevibloc
- AccessPak for HIV PEP Expanded with Viracept-Brevibloc in NaCl
- AccessPak for HIV PEP Expanded with Viracept-Brevibloc Premixed
- AccessPak for HIV PEP Expanded with Viracept-Brevibloc Premixed DS
- Brethine Subcutaneous-Accolate
- Brethine Subcutaneous-Accretropin
- Brethine Subcutaneous-Accucaine
- Brethine Subcutaneous-AccuHist Drops
- Brethine Subcutaneous-AccuHist PDX Drops
- Brethine Subcutaneous-AccuHist PDX Syrup